54.39 USD
+0.91
1.70%
At close Apr 30, 4:00 PM EDT
After hours
54.39
+0.00
0.00%
1 day
1.70%
5 days
4.58%
1 month
-8.26%
3 months
-14.67%
6 months
-37.58%
Year to date
-22.01%
1 year
-42.95%
5 years
-11.83%
10 years
-56.96%
 

About: Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.

Employees: 3,200

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

4.0% more ownership

Funds ownership: 90.47% [Q3] → 94.47% (+4.0%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q3] → 3 (+0) [Q4]

6% less repeat investments, than reductions

Existing positions increased: 119 | Existing positions reduced: 127

7% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 58

3% less funds holding

Funds holding: 364 [Q3] → 353 (-11) [Q4]

17% less capital invested

Capital invested by funds: $3.84B [Q3] → $3.18B (-$659M) [Q4]

62% less call options, than puts

Call options by funds: $2.81M | Put options by funds: $7.38M

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$58
7%
upside
Avg. target
$65
19%
upside
High target
$71
31%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Wells Fargo
Michael Sison
24% 1-year accuracy
13 / 54 met price target
7%upside
$58
Overweight
Maintained
9 Apr 2025
JP Morgan
Jeffrey Zekauskas
24% 1-year accuracy
10 / 42 met price target
31%upside
$71
Overweight
Upgraded
26 Mar 2025

Financial journalist opinion

Based on 8 articles about ASH published over the past 30 days

Positive
Zacks Investment Research
8 hours ago
Ashland (ASH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Ashland (ASH) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ashland (ASH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Negative
Zacks Investment Research
8 hours ago
Ashland (ASH) Lags Q2 Earnings and Revenue Estimates
Ashland (ASH) came out with quarterly earnings of $0.99 per share, missing the Zacks Consensus Estimate of $1.10 per share. This compares to earnings of $1.27 per share a year ago.
Ashland (ASH) Lags Q2 Earnings and Revenue Estimates
Neutral
GlobeNewsWire
11 hours ago
Ashland reports second quarter fiscal 2025 results and revises full-year outlook
WILMINGTON, Del., April 30, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the second quarter of fiscal year 2025, which ended March 31, 2025, and revised its full-year fiscal 2025 outlook. Ashland, a global additives and specialty ingredients company, holds leadership positions in high-quality, consumer-focused markets including pharmaceuticals, personal care and architectural coatings.
Ashland reports second quarter fiscal 2025 results and revises full-year outlook
Neutral
PRNewsWire
1 day ago
Ashland Place Completes Two New Financing Facilities for Sirius Aviation Capital
NEW YORK , April 29, 2025 /PRNewswire/ -- Ashland Place Finance LLC ("Ashland Place"), a commercial aviation financing platform, today announced the completion of two new facilities for Sirius Aviation Capital Holdings Limited ("Sirius"), a global aircraft lessor based in Abu Dhabi Global Market. Both A320-200s, the aircraft are currently operating on lease to ANA's Peach Aviation Limited ("Peach") in Japan and Controladora Vuela Compañía de Aviación, S.A.B.
Ashland Place Completes Two New Financing Facilities for Sirius Aviation Capital
Negative
Zacks Investment Research
1 week ago
Earnings Preview: Ashland (ASH) Q2 Earnings Expected to Decline
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Ashland (ASH) Q2 Earnings Expected to Decline
Neutral
GlobeNewsWire
1 week ago
Ashland sets date for second-quarter fiscal 2025 earnings release and conference call webcast
WILMINGTON, Del., April 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its second-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Wednesday, April 30, 2025. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 10 a.m. ET on Thursday, May 1. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com.
Ashland sets date for second-quarter fiscal 2025 earnings release and conference call webcast
Positive
Zacks Investment Research
3 weeks ago
Ashland Wraps Up Expansion of Pharmaceutical Plant in Brazil
ASH is investing in modernizing equipment for microbial protection in personal care applications at its Technical Center in Sao Paulo.
Ashland Wraps Up Expansion of Pharmaceutical Plant in Brazil
Neutral
GlobeNewsWire
4 weeks ago
Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest
Increased production capacity and market presence expected to drive competitive position and organic growth; follows previous investments in Ireland and China Increased production capacity and market presence expected to drive competitive position and organic growth; follows previous investments in Ireland and China
Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest
Neutral
GlobeNewsWire
1 month ago
Ashland to host 2025 Innovation Day for analysts and investors
WILMINGTON, Del., March 28, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is hosting an Innovation Day for analysts and investors at the company's Bridgewater, New Jersey facility, Thursday, May 29, 2025. The event will showcase the enhanced capabilities and expanded applications of Ashland's scalable technology platforms. Registration is required, with options to attend via live webcast or in person.
Ashland to host 2025 Innovation Day for analysts and investors
Neutral
Zacks Investment Research
1 month ago
Ashland Wraps Up Divestment of Avoca Business to Mane
ASH closes the sales of its Avoca business, the last entity remaining from the Pharmachem acquisition.
Ashland Wraps Up Divestment of Avoca Business to Mane
Charts implemented using Lightweight Charts™